Personal Injury

March 23, 2014

Another AndroGel Heart Attack Lawsuit Filed

AbbVie, the manufacturer of AndroGel, is exposed to another product liability lawsuit. Kimberly Dula, from Georgia claims that the company failed to warn about the heart risks from AndroGel. Dula claims that he suffered three heart attacks as a result of using the testosterone gel.

49 year old Dula filed the complaint recently in March, in the U.S. District Court for the Northern District of Illinois. There are now several Androgel lawsuits filed throughout the U.S., claiming that the drug manufacturer failed to warn about the risk of heart attacks, strokes, deep vein thrombosis, pulmonary embolism blood clots and wrongful death.

February 9, 2014

Low T Testosterone Androgel Voodoo Medicine?

by Dr. Shezad Malik

Ten years ago some scientists recruited several hundred volunteers and gave them Testosterone or a placebo. Those taking testosterone got stronger, compared with those taking the placebo, and they could carry a load up stairs faster.

But they also had nearly five times the number of cardiovascular problems, including heart attacks and strokes, and the study ended early.

February 7, 2014

Androgel Heart Attacks Lawsuits Filed in Illinois

by Dr. Shezad Malik

As previously mentioned in this blog, we believe there are serious medical risks from the use of testosterone gel supplements and plaintiffs agree with us. Several recent medical studies have found an increased risk of heart attacks from AndroGel and other testosterone treatments.

The manufacturers of the blockbuster testosterone gel are exposed to a number of lawsuits. This week men who claim injuries from the use of testosterone gels have filed lawsuits.

February 7, 2014

Takeda Actos Federal Trial Update

by Dr. Shezad Malik

Great news for folks injured by Actos diabetes drug and who have filed personal injury lawsuits. As most people know the first federal Actos trial has started on Monday February 3rd. The jury has been picked and is ready to go into a marathon trial expected to last several weeks.

Takeda Pharmaceutical Co., the manufacturer of the type 2 diabetic drug, Actos, must let a jury hear claims that it intentionally destroyed files related its Actos diabetes drug. The federal judge overseeing the trial has made this ruling, to allow this evidence and jury instruction, know as a Spoliation of Evidence. The jury is allowed to infer that the destroyed documents were damaging to the company.

February 6, 2014

Merck Agrees to $100 Million NuvaRing Blood Clot Settlement

by Dr. Shezad Malik

According to confidential sources, Merck & Co. has agreed to pay $100 million to settle more than 1,700 lawsuits. These cases allege that the NuvaRing contraceptive device causes potentially fatal blood clots in women.

The settlement, which resolves cases in federal and state courts in Missouri and New Jersey, will provide an average payout of more than $58,000 a case and will be announced tomorrow.

February 4, 2014

Stryker Rejuvenate Metal Hip Implant Lawsuits Continue to Settle

by Dr. Shezad Malik

Great news for those folks injured by a Stryker Rejuvenate metal hip implant. In a New Jersey state court Stryker Rejuvenate lawsuit case, an agreement has been reached to settle at least one more recalled Stryker Rejuvenate hip lawsuit. Recently five out of the eight cases scheduled for court-ordered mediation process have settled.

1,200 Stryker Hip Lawsuits

February 1, 2014

Thoratec HeartMate II Blood Clot Risk

by Dr. Shezad Malik

Thoratec HeartMate II Left Ventrical Assist Device (LVAD) or a Left Ventrical Assist System (LVAS), is a mechanical heart pump that is used to continuously pump blood through the heart. It is a critical bridge device for patients with advanced heart failure who are awaiting a heart transplant.

Every year, about 4,000 people are implanted with an LVAD, and about 75% receive the HeartMate II. Unfortunately it can form deadly blood clots, according to a recent medical report.

The implanted device caused 72 blood clots in 66 patients at three institutions, where 895 devices were implanted from 2004 through 2013, according to a study in the New England Journal of Medicine. The report pooled data from the Cleveland Clinic in Ohio, Washington University Barnes-Jewish Hospital in St. Louis, and Duke Medical University Center.

January 24, 2014

NuvaRing Pulmonary Embolism Lawsuits Nearing Settlement?

by Dr. Shezad Malik

Good news for women injured by Nuvaring, according to media reports, a major Nuvaring global settlement may be in the works. The first NuvaRing birth control bellwether trial scheduled to begin in the Missouri federal court has been canceled. According to a recent court order all proceedings in the Nuvaring product liability lawsuits remain stayed while settlement negotiations continue.

Nuvaring Injury Cases

January 24, 2014

Report: J&J Ethicon Vaginal Mesh Company Destroyed Crucial Files

by Dr. Shezad Malik

Injured women who have alleged product liability vaginal mesh lawsuits against Johnson & Johnson subsidiary Ethicon, have also filed a motion for sanctions. This motion claims that the manufacturer has destroyed a massive amount of data that was relevant to the litigation. Allegedly Ethicon destroyed or lost hundreds of thousands of important documents that should have been preserved.

Thousands of Ethicon Vaginal Mesh Claims

January 23, 2014

St. Jude Riata & Riata ST Lead Injury Lawsuits

by Dr. Shezad Malik

A federal judge has opened the way for St. Jude Riata defibrillator lead lawsuits to move ahead, after rejecting the manufacturer’s claim of federal preemption protection.

U.S. District Judge Selna, in the Central District of California, denied a motion to dismiss filed in five product liability lawsuits from folks who experienced injuries from St. Jude Riata leads. St. Jude Riata leads were recalled after reports that the wire insulation may fail after implantation.

St. Jude Tried to use the Federal Preemption Defense